| Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches. | |
| | |
MedLine Citation:
|
PMID: 21951628 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The conventional antihypertensive therapies including renin-angiotensin-aldosterone system antagonists (converting enzyme inhibitors, receptor blockers, renin inhibitors, and mineralocorticoid receptor blockers), diuretics, β-blockers, and calcium channel blockers are variably successful in achieving the challenging target blood pressure values in hypertensive patients. Difficult to treat hypertension is still a commonly observed problem world-wide. A number of drugs are considered to be used as novel therapies for hypertension. Renalase supplementation, vasopeptidase inhibitors, endothelin antagonists, and especially aldosterone antagonists (aldosterone synthase inhibitors and novel selective mineralocorticoid receptor blockers) are considered an option in resistant hypertension. In addition, the aldosterone antagonists as well as (pro)renin receptor blockers or AT(2) receptor agonists might attenuate end-organ damage. This array of medications has now been complemented by a number of new approaches of non-pharmacological strategies including vaccination, genomic interference, controlled breathing, baroreflex activation, and probably most successfully renal denervation techniques. However, the progress on innovative therapies seems to be slow and the problem of resistant hypertension and proper blood pressure control appears to be still persisting. Therefore the regimens of currently available drugs are being fine-tuned, resulting in the establishment of several novel fixed-dose combinations including triple combinations with the aim to facilitate proper blood pressure control. It remains an exciting question which approach will confer the best blood pressure control and risk reduction in this tricky disease. |
| | |
Authors:
|
Thomas Unger; Ludovit Paulis; Domenic A Sica |
Related Documents
:
|
7054998 - A new nonvascular interpretation of syncopal migraine. 6753448 - Treatment of diabetic orthostatic hypotension with pindolol. 3203678 - Effects of dietary copper on human autonomic cardiovascular function. 12549988 - Drug treatment of orthostatic hypotension and vasovagal syncope. 11556728 - A broadband viscoelastic spectroscopic study of bovine bone: implications for fluid flow. 9377138 - Feasibility of using finger arterial pressure in neonates. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-9-27 |
Journal Detail:
|
Title: European heart journal Volume: - ISSN: 1522-9645 ISO Abbreviation: - Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-9-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8006263 Medline TA: Eur Heart J Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Center for Cardiovascular Research, Charité-University Medicine, Hessische Str. 3-4, Berlin 10115, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Coronary {beta}2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insig...
Next Document: Biventricular pacing: current trends and future strategies.